• Immunosuppressive therapy of rheumatic diseases during pregnancy and lactation
• Management of Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, and Juvenile Idiopathic Arthritis during Pregnancy
• Pregnancy with Lupus
• Antiphospholipid Syndrome: from understanding to evolving management
• Myositis, Scleroderma, Sjögren’s and Vasculitis in pregnancy
• Revisiting Osteoporosis in reproductive years
• Recurrent Pregnancy loss and the role of IVIG therapy: myth and evidence
• From placenta pathology to adverse obstetric outcome: mechanisms and management (Preeclampsia, FGR, Placental insufficiency)
• Challenges of fertility in context of rheumatic disease and social changes
• Artificial reproductive techniques and the role of fertility preservation in rheumatic diseases
• Update on the registries
• Gender medicine
• Navigating Teratogenic Terrain: contraception and management of unintended pregnancy
• Patient perspectives: family planning with rheumatic diseases, the essential role of teamwork
• Paternal rheumatic disease and medication- influence on family planning
• Supporting new mothers with rheumatic diseases: post-partum challenges
• Long-term follow up of children

• Immunosuppressive therapy of rheumatic diseases during pregnancy and lactation
• Management of Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, and Juvenile Idiopathic Arthritis during Pregnancy
• Pregnancy with Lupus
• Antiphospholipid Syndrome: from understanding to evolving management
• Myositis, Scleroderma, Sjögren’s and Vasculitis in pregnancy
• Revisiting Osteoporosis in reproductive years
• Recurrent Pregnancy loss and the role of IVIG therapy: myth and evidence
• From placenta pathology to adverse obstetric outcome: mechanisms and management (Preeclampsia, FGR, Placental insufficiency)
• Challenges of fertility in context of rheumatic disease and social changes
• Artificial reproductive techniques and the role of fertility preservation in rheumatic diseases
• Update on the registries
• Gender medicine
• Navigating Teratogenic Terrain: contraception and management of unintended pregnancy
• Patient perspectives: family planning with rheumatic diseases, the essential role of teamwork
• Paternal rheumatic disease and medication- influence on family planning
• Supporting new mothers with rheumatic diseases: post-partum challenges
• Long-term follow up of children

The 13th European Congress on Nephrology, Internal Medicine, and Kidney Diseases is a highly anticipated event in the medical community, set to take place in Paris, France on April 16-17, 2025. The conference brings together leading nephrologists, internal medicine specialists, and kidney disease experts from around the world to share knowledge, present research, and discuss the latest advances in the field.

Attendees can look forward to a wide range of topics, including new approaches to diagnosing and treating kidney diseases, innovations in kidney transplantation, and emerging technologies for managing chronic kidney disease. The conference also provides an excellent opportunity for networking, as attendees can connect with peers, industry professionals, and leading researchers.

The program features keynote speakers, panel discussions, and workshops, as well as poster and oral presentations from researchers and clinicians. Attendees can expect to gain valuable insights into the latest research findings and clinical practices, as well as engage in stimulating discussions on the future of nephrology and kidney disease treatment.

Overall, the 13th European Congress on Nephrology, Internal Medicine, and Kidney Diseases promises to be an informative and exciting event for professionals in the field. It offers a unique opportunity to stay up-to-date on the latest advances in nephrology and kidney disease treatment, and to connect with colleagues from around the world

Theme : Global Innovations and Breakthroughs in Nephrology & Kidney Diseases.

The 13th European Congress on Nephrology, Internal Medicine, and Kidney Diseases is a highly anticipated event in the medical community, set to take place in Paris, France on April 16-17, 2025. The conference brings together leading nephrologists, internal medicine specialists, and kidney disease experts from around the world to share knowledge, present research, and discuss the latest advances in the field.

Attendees can look forward to a wide range of topics, including new approaches to diagnosing and treating kidney diseases, innovations in kidney transplantation, and emerging technologies for managing chronic kidney disease. The conference also provides an excellent opportunity for networking, as attendees can connect with peers, industry professionals, and leading researchers.

The program features keynote speakers, panel discussions, and workshops, as well as poster and oral presentations from researchers and clinicians. Attendees can expect to gain valuable insights into the latest research findings and clinical practices, as well as engage in stimulating discussions on the future of nephrology and kidney disease treatment.

Overall, the 13th European Congress on Nephrology, Internal Medicine, and Kidney Diseases promises to be an informative and exciting event for professionals in the field. It offers a unique opportunity to stay up-to-date on the latest advances in nephrology and kidney disease treatment, and to connect with colleagues from around the world

Theme : Global Innovations and Breakthroughs in Nephrology & Kidney Diseases.